Linical (2183) Q1 2025 earnings summary

Executive summary

• Net sales for 1Q FY2025 decreased by 5.0% year-over-year to ¥2,926 million, with significant declines in Japan and Asia offsetting gains in the US and Europe.

• Operating profit turned to a loss of ¥66 million from a profit of ¥112 million in the prior year, mainly due to losses in Japan and Asia despite improved performance in the US and Europe.

• Ordinary profit dropped to -¥47 million from ¥168 million.

• Net profit was -¥82 million, compared to ¥3 million in the previous year.

• Comprehensive income for the quarter was ¥287 million, a 31.4% decrease year-over-year.

Financial highlights

• Gross profit for the quarter was ¥724 million, down from ¥947 million year-over-year.

• Selling, general and administrative expenses were ¥790 million, slightly down from ¥835 million year-over-year.

• Net assets as of June 30, 2024, were ¥8,183 million, with a shareholders' equity ratio of 43.1%.

• Net income per share for the quarter was ¥3.64, compared to ¥0.16 year-over-year.

• Net asset per share as of June 30, 2024, was ¥362.32.

Outlook and guidance

• Full-year forecast for FY2025 remains unchanged: net sales of ¥12,669 million (+2.9%), operating profit of ¥1,009 million (+39.2%), ordinary profit of ¥1,047 million (+32.5%), and net profit of ¥697 million (+106.2%).

• Dividend per share forecasted at ¥16, up from ¥15 in FY2024.